F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000
The Food and Drug Administration on Wednesday approved the first-ever treatment that genetically alters a patient’s own cells to fight cancer, a milestone that is expected to transform treatment in the coming years.
August 31, 2017 at 07:31AM
via Digg http://ift.tt/2x8te86
